Adicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting - Seite 3

View source version on businesswire.com: https://www.businesswire.com/news/home/20240422828682/en/

The Adicet Bio Stock at the time of publication of the news with a raise of +2,19 % to 1,870EUR on Lang & Schwarz stock exchange (22. April 2024, 22:34 Uhr).